tiprankstipranks
Trending News
More News >
Earth Science Tech Inc (ETST)
OTHER OTC:ETST
US Market
Advertisement

Earth Science Tech (ETST) AI Stock Analysis

Compare
45 Followers

Top Page

ETST

Earth Science Tech

(OTC:ETST)

Select Model
Select Model
Select Model
Neutral 62 (OpenAI - 4o)
Rating:62Neutral
Price Target:
$0.50
▲(108.33% Upside)
Earth Science Tech's overall stock score is driven by its strong financial recovery and positive technical indicators. However, the high P/E ratio and lack of dividend yield present valuation concerns. The absence of earnings call and corporate events data limits further insights.

Earth Science Tech (ETST) vs. SPDR S&P 500 ETF (SPY)

Earth Science Tech Business Overview & Revenue Model

Company DescriptionEarth Science Tech (ETST) is a leading provider in the fields of health and wellness, specializing in the development and distribution of innovative products derived from hemp and cannabis. The company focuses on creating high-quality CBD (cannabidiol) products, including oils, edibles, and wellness supplements, targeting both consumers and businesses. ETST operates primarily in the health supplement sector and is dedicated to advancing the understanding and benefits of hemp-based products through scientific research and development.
How the Company Makes MoneyEarth Science Tech generates revenue through multiple channels, primarily by selling its CBD products directly to consumers and through wholesale distribution to retailers. The company has established a robust online presence, allowing for direct-to-consumer sales via its e-commerce platform. Additionally, ETST benefits from partnerships with various health and wellness businesses that incorporate its products into their offerings, expanding its market reach. Key revenue streams include product sales, online retail, and potential licensing agreements that may arise from its research and development efforts in the hemp industry.

Earth Science Tech Financial Statement Overview

Summary
Earth Science Tech has shown impressive revenue growth and improved gross profit margin, indicating better cost management. However, volatility in net profit margin and high leverage pose risks to financial stability.
Income Statement
60
Neutral
Earth Science Tech has shown impressive revenue growth, with a significant increase from $140,902 in 2021 to $33,117,624 in 2025. The gross profit margin has also improved, indicating better cost management. However, the net profit margin has been volatile due to fluctuating net income, impacting overall profitability stability.
Balance Sheet
55
Neutral
The company's debt-to-equity ratio has improved with a positive equity position as of 2025, contrasting with negative equity in earlier years. However, the relatively high total debt and liabilities still pose a financial stability risk. The return on equity has been erratic due to previous negative equity.
Cash Flow
65
Positive
Earth Science Tech's cash flow situation is strengthening, with significant growth in operating cash flow and positive free cash flow in recent years. The free cash flow to net income ratio suggests efficient cash generation from profits. However, earlier periods showed negative cash flows, indicating past challenges.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue33.31M33.12M11.95M48.54K14.12K140.90K
Gross Profit23.98M24.30M7.83M22.06K-8.52K39.93K
EBITDA3.41M3.54M1.04M-300.48K-224.28K-4.30M
Net Income2.64M3.25M812.14K144.58K6.66M-4.47M
Balance Sheet
Total Assets7.78M7.07M3.88M2.69M76.94K64.56K
Cash, Cash Equivalents and Short-Term Investments1.76M2.12M697.72K35.76K26.94K16.16K
Total Debt285.59K401.24K246.59K974.11K682.45K650.44K
Total Liabilities3.49M3.22M1.63M1.61M1.88M5.09M
Stockholders Equity4.24M3.85M2.25M1.08M-1.81M-5.03M
Cash Flow
Free Cash Flow2.87M3.62M1.18M-1.01M-166.39K-196.69K
Operating Cash Flow3.76M4.37M1.21M-1.01M-168.11K-196.69K
Investing Cash Flow-2.45M-1.88M-26.52K0.001.71K0.00
Financing Cash Flow-1.82M-1.72M-517.88K1.02M173.18K182.12K

Earth Science Tech Technical Analysis

Technical Analysis Sentiment
Negative
Last Price0.24
Price Trends
50DMA
0.18
Negative
100DMA
0.18
Negative
200DMA
0.17
Negative
Market Momentum
MACD
>-0.01
Negative
RSI
45.49
Neutral
STOCH
56.38
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For ETST, the sentiment is Negative. The current price of 0.24 is above the 20-day moving average (MA) of 0.17, above the 50-day MA of 0.18, and above the 200-day MA of 0.17, indicating a bearish trend. The MACD of >-0.01 indicates Negative momentum. The RSI at 45.49 is Neutral, neither overbought nor oversold. The STOCH value of 56.38 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for ETST.

Earth Science Tech Risk Analysis

Earth Science Tech disclosed 38 risk factors in its most recent earnings report. Earth Science Tech reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Earth Science Tech Peers Comparison

Overall Rating
UnderperformOutperform
Sector (51)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
$45.91M17.7371.39%64.06%37.50%
$48.02M-15.05-10.79%11.34%71.13%
$7.86B-0.30-43.30%2.27%22.53%-2.21%
$38.22M-16.64-8.65%-6.79%61.56%
$62.46M-3.36-117.56%-93.22%36.97%
$27.67M-1.56-37.22%-66.30%50.52%
$31.63M-1.03-52.69%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
ETST
Earth Science Tech
0.24
0.11
84.62%
TLPH
Talphera
1.34
0.45
50.56%
RMTI
Rockwell Med
1.11
-2.78
-71.47%
SCYX
SCYNEXIS
0.66
-0.66
-50.00%
CPIX
Cumberland Pharmaceuticals
2.99
1.85
162.28%
COSM
Cosmos Holdings
0.81
0.11
15.71%

Earth Science Tech Corporate Events

Business Operations and Strategy
Earth Science Tech Reduces Authorized Shares by 50 Million
Positive
Aug 19, 2025

On August 19, 2025, Earth Science Tech, Inc. announced that its Board of Directors approved a reduction in the company’s authorized shares of common stock from 350 million to 300 million. This decision reflects the board’s confidence in the company’s financial health and strategic plan, aiming to prevent unnecessary shareholder dilution and protect long-term shareholder value.

Business Operations and StrategyFinancial Disclosures
Earth Science Tech Reports 61% Asset Growth in Q1 2025
Positive
Aug 8, 2025

On August 8, 2025, Earth Science Tech, Inc. reported a 61% growth in total assets to $7.69 million and revenue of $8.7 million for the first quarter ending June 30, 2025. This growth follows a foundational quarter of strategic acquisitions, including healthcare and direct-to-consumer brands, and marks a shift from acquisitions to enhancing the value and profitability of existing divisions. The company also reduced its outstanding shares by 4.78% and continued to expand its operational infrastructure, including a new customer service center and real estate development projects.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Nov 01, 2025